Danaher nears $10 bln deal to buy med tech firm Masimo- FT
#Danaher #Masimo #acquisition #medical technology #MedTech #$10 billion
📌 Key Takeaways
- Danaher seeks to acquire MedTech firm Masimo in a deal valued around $10 billion.
- The transaction is in advanced stages of negotiation.
- Masimo is a U.S.-based medical technology company specializing in patient monitoring and diagnostics.
- The acquisition aims to strengthen Danaher’s position in the medical technology market.
- The deal reflects broader corporate strategies to expand through strategic acquisitions.
📖 Full Retelling
Danaher, a diversified industrial conglomerate, is reportedly close to finalizing a roughly $10 billion acquisition of Masimo, a U.S.-based medical technology company. The negotiations are taking place now, with the deal aimed at expanding Danaher's footprint in the growing medical monitoring and diagnostics sector.
🏷️ Themes
Corporate mergers and acquisitions, Medical technology, Strategic market expansion, Industry consolidation
Entity Intersection Graph
No entity connections available yet for this article.